Nav: Home

Defective cilia linked to heart valve birth defects

September 16, 2019

Bicuspid aortic valve (BAV) is the most common heart valve birth defect and one of the most common birth defects of any type, affecting around 70 million people worldwide. A healthy aortic valve has three leaflets; in BAV disease, two of the leaflets are fused together, impairing the function of the valve. In many individuals with BAV, the valves eventually will have to be replaced or repaired through heart surgery.

A team of researchers at the Medical University of South Carolina (MUSC) have discovered that a mutation in a gene controlling the production of cilia, tiny antennae protruding from the cell surface, are linked to the development of BAV.

In an article published online August 7, 2019 in the journal Circulation, the team used animal models and human data to reveal that BAV disease and aortic valve narrowing are caused by disruption of the exocyst, a shuttling complex that moves cilia cargo to the cell membrane and allows for the development of cilia, and defects in cilia production.

Most cells have cilia, which help them "sense" their surroundings.

"You can think of cilia like tiny antennae that cells use to transmit information to each other," said Diana Fulmer, Ph.D. candidate at MUSC and lead author of the manuscript. "In heart valves, cilia function as signaling hubs during development to coordinate how cells and extracellular matrix arrange to form mature tissue."

Only recently has the medical community begun to realize how cilia are involved in human health and disease.

"Up until 20 years ago, people were writing that cilia were vestigial organelles and had no function," said Joshua H. Lipschutz, M.D., professor of medicine and director of the Division of Nephrology at MUSC and co-senior author of the article. "Now, there's a whole field of ciliopathies."

Russell A. Norris, Ph.D., associate professor of medicine in the Department of Regenerative Medicine and Cell Biology at MUSC and an expert in heart valve biology and genetics, is co-senior author of the manuscript. Norris first started to suspect that cilia were involved in BAV disease when he noticed that patients with certain ciliopathies, or cilia diseases, also had BAV disease. This observation led to a collaboration with Lipschutz, who studies autosomal dominant polycystic kidney disease, or ADPKD, which is a cilia disease affecting the kidney.

"We knew that ADPKD patients have a much higher incidence of heart defects, including bicuspid aortic valve disease," said Lipschutz. "So, there was a very strong clinical association."

Norris and Lipschutz wrote a collaborative grant with Simon Body, M.D., director of the Bicuspid Aortic Valve Consortium and an associate professor of anaesthesia at Harvard Medical School, to find out how cilia contribute to BAV disease. "It was really a true collaboration," said Lipschutz. The grant was funded through the American Heart Association.

The investigators first compared the genomes of healthy adults and adults with BAV disease. In a genome-wide association study, the most associated differences in genomes were found in or near genes that are important in regulating ciliogenesis through the exocyst.

Animal models were then used to determine whether mutations in a central exocyst protein, Exoc5, caused disease in other organisms. Knocking out or "disabling" the gene for Exoc5 in zebrafish severely obstructed blood flow from the heart, leading to poor cardiac function and early death. The zebrafish also showed signs of other ciliopathies.

Remarkably, injecting the correct gene sequence for Exoc5 into the zebrafish prevented them from developing heart defects, proving that the mutation was causing the disease.

The investigators then disabled the Exoc5 gene in mice, specifically in the cells that make up the cardiac valves. Mice with both copies of the disabled gene died early during development. Mice with only one copy of the disabled gene were born but had a high rate of BAV disease and problems with cilia production.

Humans with BAV disease often develop calcification on their aortic valve, leading to stenosis, or narrowing, of the valve opening. This can cause severe functional defects within the heart and is a major indication for surgery.

Interestingly, mice with the disabled exocyst gene also developed calcified aortic valves and had significantly larger aortic roots.

"We saw the same thing we see in people," said Lipschutz. "This gives us a good animal model for the disease."

This study provides novel insight into the origin of BAV disease.

"We showed that the cause of a very common, potentially lethal, genetic defect in people was due to cilia and the exocyst," Lipschutz said.

Knowledge gained from the study should accelerate the development of new therapies.

"Finding the cause for disease is the first step to finding a cure," said Lipschutz. "Now that we know what's causing it, we can come up with ways to treat it without surgery."
About MUSC

Founded in 1824 in Charleston, MUSC is the oldest medical school in the South, as well as the state's only integrated, academic health sciences center with a unique charge to serve the state through education, research and patient care. Each year, MUSC educates and trains more than 3,000 students and 700 residents in six colleges: Dental Medicine, Graduate Studies, Health Professions, Medicine, Nursing and Pharmacy. The state's leader in obtaining biomedical research funds, in fiscal year 2018, MUSC set a new high, bringing in more than $276.5 million. For information on academic programs, visit

As the clinical health system of the Medical University of South Carolina, MUSC Health is dedicated to delivering the highest quality patient care available, while training generations of competent, compassionate health care providers to serve the people of South Carolina and beyond. Comprising some 1,600 beds, more than 100 outreach sites, the MUSC College of Medicine, the physicians' practice plan, and nearly 275 telehealth locations, MUSC Health owns and operates eight hospitals situated in Charleston, Chester, Florence, Lancaster and Marion counties. In 2019, for the fifth consecutive year, U.S. News & World Report named MUSC Health the number one hospital in South Carolina. To learn more about clinical patient services, visit

MUSC and its affiliates have collective annual budgets of $3 billion. The more than 17,000 MUSC team members include world-class faculty, physicians, specialty providers and scientists who deliver groundbreaking education, research, technology and patient care.

Medical University of South Carolina

Related Zebrafish Articles:

How do zebrafish get their stripes? New data analysis tool could provide an answer
A new mathematical tool developed at Brown could help scientists better understand how zebrafish get their stripes as well as other self-assembled patterns in nature.
Zebrafish teach researchers more about atrial fibrillation
Genetic research in zebrafish at the University of Copenhagen has surprised the researchers behind the study.
How decisions unfold in a zebrafish brain
Researchers were able to track the activity of each neuron in the entire brain of zebrafish larvae and reconstruct the unfolding of neuronal events as the animals repeatedly made 'left or right' choices in a behavioral experiment.
'Census' in the zebrafish's brain
Dresden scientists have succeeded in determining the number and type of newly formed neurons in zebrafish; practically conducting a 'census' in their brains.
Zebrafish 'avatars' can help decide who should receive radiotherapy treatment
To date, there is no method for clearly determining whether radiotherapy will be an effective treatment for individual cancer patients.
Special cells contribute to regenerate the heart in Zebrafish
It is already known that zebrafish can flexibly regenerate their hearts after injury.
Survival of the zebrafish: Mate, or flee?
*Researchers have found that when making decisions that are important to the species' survival, zebrafish choose to mate rather than to flee from a threat.
Zebrafish capture a 'window' on the cancer process
Cancer-related inflammation impacts significantly on cancer development and progression. New research has observed in zebrafish, for the first time, that inflammatory cells use weak spots or micro-perforations in the extracellular matrix barrier layer to access skin cancer cells.
How a zebrafish could help solve the mysteries of genetic brain disease
A close look at the rapidly developing zebrafish embryo is helping neuroscientists better understand the potential underpinnings of brain disorders, including autism and schizophrenia.
Zebrafish help unlock mystery of motor neurone disease
Scientists from the University of Sheffield have successfully created zebrafish that carry the complex genetic change known to cause the most common genetic form of motor neurone disease (MND).
More Zebrafish News and Zebrafish Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at